Companies / Materials
IFF
International Flavors & Fragrances
Specialty Chemicals
Specialty ChemicalsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health29
Growth9
Profitability12
Cash generation25
Balance sheet20
Dilution control78
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)3.9%Revenue growth (FY)-5.2%Revenue CAGR (3y)-4.3%Gross margin36.2%Operating margin-3.5%Net margin-3.3%Free cash flow margin2.4%R&D / revenue6.4%Stock comp / revenue0.8%Net debt / operating cash flow7.78xCurrent ratio1.42Diluted share count change0.0%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $11.7B | $12.4B | $11.5B | $11.5B | $10.9B |
| Gross profit | $3.7B | $4.2B | $3.7B | $4.1B | $3.9B |
| Operating income | $585M | -$1.3B | -$2.1B | $766M | -$382M |
| Net income | $279M | -$1.9B | -$2.6B | $267M | -$359M |
| Operating cash flow | $1.4B | $397M | $1.5B | $1.1B | $850M |
| Capital expenditure | $393M | $504M | $503M | $463M | $594M |
| Free cash flow | $1.0B | -$107M | $952M | $607M | $256M |
| R&D | $629M | $603M | $636M | $671M | $694M |
| Stock-based comp | $54M | $49M | $65M | $77M | $88M |
| Buybacks | — | — | $0 | $0 | $38M |
| Dividends | $667M | $810M | $826M | $514M | $409M |
| Cash | $711M | $483M | $703M | $469M | $590M |
| Total debt | $11.9B | $11.4B | $10.9B | $10.3B | $7.2B |
| Equity | $21.1B | $17.7B | $14.6B | $13.8B | $14.2B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.